We are live on
!
Find out more
HEC
Hudson Executive Capital Portfolio holdings
AUM
$151M
1-Year Est. Return
60.14%
This Fund
S&P 500
This Quarter
Est. Return
+7.98%
1 Year Est. Return
+60.14%
3 Year Est. Return
+143.92%
5 Year Est. Return
+104.85%
10 Year Est. Return
+677.02%
AUM
$829M
AUM Growth
-$10.1M
(-1.2%)
Cap. Flow
-$13.9M
Cap. Flow
% of AUM
-1.68%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
6
New
–
Increased
1
Reduced
–
Closed
1
Top Buys
No buys this quarter
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AKYA
Akoya BioSciences
AKYA
|
+$14.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 85.35% |
| 2 | Technology | 11.76% |
| 3 | Healthcare | 1.5% |
Similar funds
SHF
FWM
CCM
DIG
BDS
MWA
WBCM
CAM
Hudson Executive Capital's Q2 2023 Portfolio in Review
As of Q2 2023, Hudson Executive Capital held 6 positions worth $829M, down 1.2% from $839M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Hudson Executive Capital's Q2 2023 filing shows 1 increased and 1 closed positions. The largest sale was Akoya BioSciences, an estimated $14.2M.
By sector, the portfolio is most concentrated in Financials at 85% of assets, up from 82% a quarter earlier, followed by Technology and Healthcare.
- Hudson Executive Capital fully exited Akoya BioSciences in Q2 2023, selling an estimated $14.2M.
- Hudson Executive Capital's ten largest holdings make up 100% of its $829M portfolio in Q2 2023.
- Hudson Executive Capital opened 0 new positions and closed 1 in Q2 2023.
- Hudson Executive Capital's portfolio value fell 1.2% quarter-over-quarter to $829M.
Based on Hudson Executive Capital's 13F filing for Q2 2023, filed 14 Aug 2023.